Literature DB >> 16622704

Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).

Ronald P J Oude Elferink1, Coen C Paulusma.   

Abstract

Like several other ATP-binding cassette (ABC) transporters, ABCB4 is a lipid translocator. It translocates phosphatidylcholine (PC) from the inner to the outer leaflet of the canalicular membrane of the hepatocyte. Its function is quite crucial as evidenced by a severe liver disease, progressive familial intrahepatic cholestasis type 3, which develops in persons with ABCB4 deficiency. Translocation of PC makes the phospholipid available for extraction into the canalicular lumen by bile salts. The primary function of biliary phospholipid excretion is to protect the membranes of cells facing the biliary tree against these bile salts: the uptake of PC in bile salt micelles reduces the detergent activity of these micelles. In this review, we will discuss the functional aspects of ABCB4 and the regulation of its expression. Furthermore, we will describe the clinical and biochemical consequences of complete and partial deficiency of ABCB4 function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16622704     DOI: 10.1007/s00424-006-0062-9

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  87 in total

1.  The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood.

Authors:  E Jacquemin; J M De Vree; D Cresteil; E M Sokal; E Sturm; M Dumont; G L Scheffer; M Paul; M Burdelski; P J Bosma; O Bernard; M Hadchouel; R P Elferink
Journal:  Gastroenterology       Date:  2001-05       Impact factor: 22.682

2.  MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine.

Authors:  A van Helvoort; A J Smith; H Sprong; I Fritzsche; A H Schinkel; P Borst; G van Meer
Journal:  Cell       Date:  1996-11-01       Impact factor: 41.582

3.  Developmental expression of canalicular transporter genes in human liver.

Authors:  Huey-Ling Chen; Hui-Ling Chen; Yu-Jung Liu; Chun-Hsiang Feng; Chao-Yi Wu; Ming-Kwang Shyu; Ray-Hwang Yuan; Mei-Hwei Chang
Journal:  J Hepatol       Date:  2005-09       Impact factor: 25.083

4.  Clinical and biochemical findings in progressive familial intrahepatic cholestasis.

Authors:  P F Whitington; D K Freese; E M Alonso; S J Schwarzenberg; H L Sharp
Journal:  J Pediatr Gastroenterol Nutr       Date:  1994-02       Impact factor: 2.839

5.  Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.

Authors:  P H Dixon; N Weerasekera; K J Linton; O Donaldson; J Chambers; E Egginton; J Weaver; C Nelson-Piercy; M de Swiet; G Warnes; E Elias; C F Higgins; D G Johnston; M I McCarthy; C Williamson
Journal:  Hum Mol Genet       Date:  2000-05-01       Impact factor: 6.150

6.  Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy.

Authors:  A R Crawford; A J Smith; V C Hatch; R P Oude Elferink; P Borst; J M Crawford
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

7.  Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse.

Authors:  R P Elferink; R Ottenhoff; J van Marle; C M Frijters; A J Smith; A K Groen
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

8.  Imaging biliary lipid secretion in the rat: ultrastructural evidence for vesiculation of the hepatocyte canalicular membrane.

Authors:  J M Crawford; G M Möckel; A R Crawford; S J Hagen; V C Hatch; S Barnes; J J Godleski; M C Carey
Journal:  J Lipid Res       Date:  1995-10       Impact factor: 5.922

9.  The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice.

Authors:  A J Smith; J L Timmermans-Hereijgers; B Roelofsen; K W Wirtz; W J van Blitterswijk; J J Smit; A H Schinkel; P Borst
Journal:  FEBS Lett       Date:  1994-11-14       Impact factor: 4.124

10.  A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol.

Authors:  Eric L Klett; Kangmo Lu; Astrid Kosters; Edwin Vink; Mi-Hye Lee; Michael Altenburg; Sarah Shefer; Ashok K Batta; Hongwei Yu; Jianliang Chen; Richard Klein; Norbert Looije; Ronald Oude-Elferink; Albert K Groen; Nobuyo Maeda; Gerald Salen; Shailendra B Patel
Journal:  BMC Med       Date:  2004-03-24       Impact factor: 8.775

View more
  67 in total

1.  Mouse models of liver fibrosis mimic human liver fibrosis of different etiologies.

Authors:  Allyson K Martínez; Luca Maroni; Marco Marzioni; Syed T Ahmed; Mena Milad; Debolina Ray; Gianfranco Alpini; Shannon S Glaser
Journal:  Curr Pathobiol Rep       Date:  2014-12-01

2.  ABCB4 mediates diet-induced hypercholesterolemia in laboratory opossums.

Authors:  Jeannie Chan; Michael C Mahaney; Rampratap S Kushwaha; Jane F VandeBerg; John L VandeBerg
Journal:  J Lipid Res       Date:  2010-05-20       Impact factor: 5.922

Review 3.  Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)Fluoro-D-Glucose.

Authors:  Ana F Brito; Mónica Mendes; Ana M Abrantes; José G Tralhão; Maria F Botelho
Journal:  Mol Diagn Ther       Date:  2014-10       Impact factor: 4.074

4.  Two ABCB4 point mutations of strategic NBD-motifs do not prevent protein targeting to the plasma membrane but promote MDR3 dysfunction.

Authors:  Dario Degiorgio; Paola A Corsetto; Angela M Rizzo; Carla Colombo; Manuela Seia; Lucy Costantino; Gigliola Montorfano; Rossella Tomaiuolo; Domenico Bordo; Serena Sansanelli; Min Li; Daniela Tavian; Maria P Rastaldi; Domenico A Coviello
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

5.  Embryonic cholecystitis and defective gallbladder contraction in the Sox17-haploinsufficient mouse model of biliary atresia.

Authors:  Hiroki Higashiyama; Aisa Ozawa; Hiroyuki Sumitomo; Mami Uemura; Ko Fujino; Hitomi Igarashi; Kenya Imaimatsu; Naoki Tsunekawa; Yoshikazu Hirate; Masamichi Kurohmaru; Yukio Saijoh; Masami Kanai-Azuma; Yoshiakira Kanai
Journal:  Development       Date:  2017-04-21       Impact factor: 6.868

Review 6.  Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.

Authors:  Michael Trauner; Peter Fickert; Emina Halilbasic; Tarek Moustafa
Journal:  Wien Med Wochenschr       Date:  2008

Review 7.  Dynamics of hepatic and intestinal cholesterol and bile acid pathways: The impact of the animal model of estrogen deficiency and exercise training.

Authors:  Jean-Marc Lavoie
Journal:  World J Hepatol       Date:  2016-08-18

8.  Genetic polymorphisms of OCT-1 confer susceptibility to severe progression of primary biliary cirrhosis in Japanese patients.

Authors:  Yuki Ohishi; Makoto Nakamuta; Naoko Ishikawa; Ohki Saitoh; Hitomi Nakamura; Yoshihiro Aiba; Atsumasa Komori; Kiyoshi Migita; Hiroshi Yatsuhashi; Nobuyoshi Fukushima; Motoyuki Kohjima; Tsuyoshi Yoshimoto; Kunitaka Fukuizumi; Makoto Ishibashi; Takashi Nishino; Ken Shirabe; Akinobu Taketomi; Yoshihiko Maehara; Hiromi Ishibashi; Minoru Nakamura
Journal:  J Gastroenterol       Date:  2013-04-24       Impact factor: 7.527

9.  The Na+/H+ exchanger NHE6 in the endosomal recycling system is involved in the development of apical bile canalicular surface domains in HepG2 cells.

Authors:  Ryuichi Ohgaki; Masafumi Matsushita; Hiroshi Kanazawa; Satoshi Ogihara; Dick Hoekstra; Sven C D van Ijzendoorn
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

10.  An insertion mutation in ABCB4 is associated with gallbladder mucocele formation in dogs.

Authors:  Katrina L Mealey; Jonathan D Minch; Stephen N White; Kevin R Snekvik; John S Mattoon
Journal:  Comp Hepatol       Date:  2010-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.